Fig. 2
From: mTOR inhibition abrogates human mammary stem cells and early breast cancer progression markers
Effect of sirolimus treatment on mammary epithelial populations. Scatter plots for comparison of BM populations between sirolimus-treated patients (n = 27) and controls (n = 18) A, between treatment (n = 6) and control (n = 8) groups of pre-menopausal patients B, and between treatment (n = 21) and control (10) groups of postmenopausal patients C using unpaired t-tests. LP populations are shown between groups D and in pre- and postmenopausal derived patients E & F. ML populations are shown between groups G and in pre- and postmenopausal derived patients H & I